|
1.
|
Mazor KM, Rogers HJ, Williams AE, Roblin DW, Gaglio B, Field TS, Greene SM, Han PK, Costanza ME. The Cancer Message Literacy Tests: Psychometric analyses and validity studies. Patient Educ Couns. 2012 Oct; 89(1):69-75.
|
|
|
|
|
2.
|
Costanza ME. Screening mammograms should not be underestimated. Arch Intern Med. 2012 Mar 12; 172(5):446.
|
|
|
|
|
3.
|
Mazor KM, Roblin DW, Williams AE, Greene SM, Gaglio B, Field TS, Costanza ME, Han PK, Saccoccio L, Calvi J, Cove E, Cowan R. Health literacy and cancer prevention: Two new instruments to assess comprehension. Patient Educ Couns. 2012 Jul; 88(1):54-60.
|
|
|
|
|
4.
|
Costanza ME, Luckmann R, White MJ, Rosal MC, Cranos C, Reed G, Clark R, Sama S, Yood R. Design and methods for a randomized clinical trial comparing three outreach efforts to improve screening mammography adherence. BMC Health Serv Res. 2011; 11:145.
|
|
|
|
|
5.
|
Costanza ME, Luckmann RS, Rosal M, White MJ, Lapelle N, Partin M, Cranos C, Leung KG, Foley C. Helping men make an informed decision about prostate cancer screening: A pilot study of telephone counseling. Patient Educ Couns. 2011 Feb; 82(2):193-200.
|
|
|
|
|
6.
|
Mazor KM, Calvi J, Cowan R, Costanza ME, Han PK, Greene SM, Saccoccio L, Cove E, Roblin D, Williams A. Media messages about cancer: what do people understand? J Health Commun. 2010; 15 Suppl 2:126-45.
|
|
|
|
|
7.
|
Costanza ME, Luckmann R, White MJ, Rosal MC, LaPelle N, Cranos C. Moving mammogram-reluctant women to screening: a pilot study. Ann Behav Med. 2009 Jun; 37(3):343-9.
|
|
|
|
|
8.
|
Rider EA, Brashers VL, Costanza ME. Using interprofessional team-based learning to develop health care policy. Med Educ. 2008 May; 42(5):519-20.
|
|
|
|
|
9.
|
LaPelle N, Costanza ME, Luckmann R, Rosal MC, White MJ, Stark JR. Staging mammography nonadherent women: a qualitative study. J Cancer Educ. 2008; 23(2):114-21.
|
|
|
|
|
10.
|
Costanza ME. Why don't people adopt recommended health behaviors? J Cancer Educ. 2008; 23(3):138-9.
|
|
|
|
|
11.
|
Costanza ME, Luckmann R, Stoddard AM, White MJ, Stark JR, Avrunin JS, Rosal MC, Clemow L. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening. Cancer Detect Prev. 2007; 31(3):191-8.
|
|
|
|
|
12.
|
Coughlin SS, Costanza ME, Fernandez ME, Glanz K, Lee JW, Smith SA, Stroud L, Tessaro I, Westfall JM, Weissfeld JL, Blumenthal DS. CDC-funded intervention research aimed at promoting colorectal cancer screening in communities. Cancer. 2006 Sep 1; 107(5 Suppl):1196-204.
|
|
|
|
|
13.
|
Stark JR, Bertone-Johnson ER, Costanza ME, Stoddard AM. Factors associated with colorectal cancer risk perception: the role of polyps and family history. Health Educ Res. 2006 Oct; 21(5):740-9.
|
|
|
|
|
14.
|
Costanza ME, Luckmann R, Stoddard AM, Avrunin JS, White MJ, Stark JR, Clemow L, Rosal MC. Applying a stage model of behavior change to colon cancer screening. Prev Med. 2005 Sep-Oct; 41(3-4):707-19.
|
|
|
|
|
15.
|
White MJ, Stark JR, Luckmann R, Rosal MC, Clemow L, Costanza ME. Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation. Patient Educ Couns. 2006 Jun; 61(3):419-28.
|
|
|
|
|
16.
|
Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP, Foster RS, Hendrick E, Eyre HJ, Sener S. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003 May-Jun; 53(3):141-69.
|
|
|
|
|
17.
|
Luckmann R, Savageau JA, Clemow L, Stoddard AM, Costanza ME. A randomized trial of telephone counseling to promote screening mammography in two HMOs. Cancer Detect Prev. 2003; 27(6):442-50.
|
|
|
|
|
18.
|
Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM. High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 2002 Feb 1; 20(3):743-50.
|
|
|
|
|
19.
|
Stoddard AM, Fox SA, Costanza ME, Lane DS, Andersen MR, Urban N, Lipkus I, Rimer BK. Effectiveness of telephone counseling for mammography: results from five randomized trials. Prev Med. 2002 Jan; 34(1):90-9.
|
|
|
|
|
20.
|
Costanza ME, Stoddard AM, Luckmann R, White MJ, Spitz Avrunin J, Clemow L. Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention. Am J Prev Med. 2000 Jul; 19(1):39-46.
|
|
|
|
|
21.
|
Clemow L, Costanza ME, Haddad WP, Luckmann R, White MJ, Klaus D, Stoddard AM. Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram. Ann Behav Med. 2000; 22(1):80-8.
|
|
|
|
|
22.
|
Costanza ME, Luckmann R, Quirk ME, Clemow L, White MJ, Stoddard AM. The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam. Prev Med. 1999 Oct; 29(4):241-8.
|
|
|
|
|
23.
|
Costanza ME, Weiss RB, Henderson IC, Norton L, Berry DA, Cirrincione C, Winer E, Wood WC, Frei E, McIntyre OR, Schilsky RL. Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642. J Clin Oncol. 1999 May; 17(5):1397-406.
|
|
|
|
|
24.
|
Stoddard AM, Rimer BK, Lane D, Fox SA, Lipkus I, Luckmann R, Avrunin JS, Sprachman S, Costanza M, Urban N. Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium. Prev Med. 1998 May-Jun; 27(3):478-87.
|
|
|
|
|
25.
|
Rakowski W, Andersen MR, Stoddard AM, Urban N, Rimer BK, Lane DS, Fox SA, Costanza ME. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol. 1997 Sep; 16(5):433-41.
|
|
|
|
|
26.
|
Pokorski RJ, Sanderson P, Bennett N, Costanza M, Dicke AA, Eyre H, Hall PH, Hausman S, Lynch J, Meyer RB, Sener S, Wender R, Zeitz K. Insurance issues and genetic testing: challenges and recommendations: workshop no. 1. Cancer. 1997 Aug 1; 80(3 Suppl):627.
|
|
|
|
|
27.
|
Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, Smith RA. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 1997 May-Jun; 47(3):150-3.
|
|
|
|
|
28.
|
Costanza ME, Edmiston KL. Breast cancer screening: early recognition. Compr Ther. 1997 Jan; 23(1):7-12.
|
|
|
|
|
29.
|
Byers T, Costanza ME, Kattlove H. Screening mammography. When should it stop? Cancer Pract. 1997 Jan-Feb; 5(1):52-4.
|
|
|
|
|
30.
|
Costanza ME, Berry D, Henderson IC, Ratain MJ, Wu K, Shapiro C, Duggan D, Kalra J, Berkowitz I, Lyss AP. Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642). Clin Cancer Res. 1995 Jul; 1(7):699-704.
|
|
|
|
|
31.
|
Ratain MJ, Rosner G, Allen SL, Costanza M, Van Echo DA, Henderson IC, Schilsky RL. Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study. J Clin Oncol. 1995 Mar; 13(3):741-7.
|
|
|
|
|
32.
|
Costanza ME, Greene HL, McManus D, Hoople NE, Barth R. Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study. J Cancer Educ. 1995; 10(1):14-21.
|
|
|
|
|
33.
|
Costanza ME. Issues in breast cancer screening in older women. Cancer. 1994 Oct 1; 74(7 Suppl):2009-15.
|
|
|
|
|
34.
|
Costanza ME. The extent of breast cancer screening in older women. Cancer. 1994 Oct 1; 74(7 Suppl):2046-50.
|
|
|
|
|
35.
|
Zapka JG, Harris DR, Hosmer D, Costanza ME, Mas E, Barth R. Effect of a community health center intervention on breast cancer screening among Hispanic American women. Health Serv Res. 1993 Jun; 28(2):223-35.
|
|
|
|
|
36.
|
Costanza ME, Hoople NE, Gaw VP, Stoddard AM. Cancer prevention practices and continuing education needs of primary care physicians. Am J Prev Med. 1993 Mar-Apr; 9(2):107-12.
|
|
|
|
|
37.
|
Zapka JG, Costanza ME, Harris DR, Hosmer D, Stoddard A, Barth R, Gaw V. Impact of a breast cancer screening community intervention. Prev Med. 1993 Jan; 22(1):34-53.
|
|
|
|
|
38.
|
Costanza ME. Phase II studies: untreated breast cancer patients. J Natl Cancer Inst. 1992 Dec 2; 84(23):1833.
|
|
|
|
|
39.
|
Costanza ME. Breast cancer screening in older women: overview. J Gerontol. 1992 Nov; 47 Spec No:1-3.
|
|
|
|
|
40.
|
Costanza ME, Annas GJ, Brown ML, Cassel CK, Champion V, Cohen HJ, Frame PS, Glasse L, Mor V, Pauker SG. Supporting statements and rationale. J Gerontol. 1992 Nov; 47 Spec No:7-16.
|
|
|
|
|
41.
|
Costanza ME, Zapka JG, Harris DR, Hosmer D, Barth R, Gaw VP, Greene HL, Stoddard AM. Impact of a physician intervention program to increase breast cancer screening. Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec; 1(7):581-9.
|
|
|
|
|
42.
|
Zapka JG, Hosmer D, Costanza ME, Harris DR, Stoddard A. Changes in mammography use: economic, need, and service factors. Am J Public Health. 1992 Oct; 82(10):1345-51.
|
|
|
|
|
43.
|
Costanza ME, Stoddard A, Gaw VP, Zapka JG. The risk factors of age and family history and their relationship to screening mammography utilization. J Am Geriatr Soc. 1992 Aug; 40(8):774-8.
|
|
|
|
|
44.
|
Costanza ME. Breast cancer screening in older women. Synopsis of a forum. Cancer. 1992 Apr 1; 69(7 Suppl):1925-31.
|
|
|
|
|
45.
|
Shapiro S, Smart CR, Costanza ME, Henson DE, Holleb AI, Hutter RV, Krammer B, Kushner HD, McLelland R, Moskowitz M, et al. Guidelines for breast cancer screening. Cancer. 1992 Apr 1; 69(7 Suppl):2001-2.
|
|
|
|
|
46.
|
Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhancers. J Am Board Fam Pract. 1992 Mar-Apr; 5(2):143-52.
|
|
|
|
|
47.
|
Costanza ME. Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer? Womens Health Issues. 1992; 2(4):220-7; discussion 227-35.
|
|
|
|
|
48.
|
Zapka JG, Chasan L, Barth R, Mas E, Costanza ME. Emphasizing screening activities in a community health center: a case study of a breast cancer screening project. J Ambul Care Manage. 1992 Jan; 15(1):38-47.
|
|
|
|
|
49.
|
Zapka JG, Harris DR, Stoddard AM, Costanza ME. Validity and reliability of psychosocial factors related to breast cancer screening. Eval Health Prof. 1991 Sep; 14(3):356-67.
|
|
|
|
|
50.
|
Costanza ME, D'Orsi CJ, Greene HL, Gaw VP, Karellas A, Zapka JG. Feasibility of universal screening mammography. Lessons from a community intervention. Arch Intern Med. 1991 Sep; 151(9):1851-6.
|
|
|
|
|
51.
|
Zapka JG, Stoddard A, Maul L, Costanza ME. Interval adherence to mammography screening guidelines. Med Care. 1991 Aug; 29(8):697-707.
|
|
|
|
|
52.
|
Gaw VP, Bush SM, D'Orsi CJ, Costanza ME, Karellas A, Dowd M, Zapka JG. A program to improve mammography skills of practicing radiologic technologists. QRB Qual Rev Bull. 1991 Feb; 17(2):48-53.
|
|
|
|
|
53.
|
Dawson NA, Costanza ME, Korzun AH, Clamon GH, Pollak M, Vogelzang NJ, Carey RW, Norton L. Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study. Med Pediatr Oncol. 1991; 19(4):283-8.
|
|
|
|
|
54.
|
Grem JL, King SA, Costanza ME, Brown TD. Hypersensitivity reactions to trimetrexate. Invest New Drugs. 1990 May; 8(2):211-4.
|
|
|
|
|
55.
|
Kreisman H, Goutsou M, Modeas C, Graziano SL, Costanza ME, Green MR. Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study. Eur J Cancer. 1990; 26(10):1057-60.
|
|
|
|
|
56.
|
Budman DR, Korzun AH, Aisner J, Younger J, Silver R, Costanza M, Rice MA, Wood W. A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443. Cancer Invest. 1990; 8(6):571-5.
|
|
|
|
|
57.
|
Zapka JG, Costanza ME, Stoddard A, Green HL. Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women. Prog Clin Biol Res. 1990; 339:253-7.
|
|
|
|
|
58.
|
Stoddard AM, Zapka JG, Schoenfeld S, Costanza ME. Effects of a news event on breast cancer screening survey responses. Prog Clin Biol Res. 1990; 339:259-68.
|
|
|
|
|
59.
|
Zapka JG, Stoddard AM, Costanza ME, Greene HL. Breast cancer screening by mammography: utilization and associated factors. Am J Public Health. 1989 Nov; 79(11):1499-502.
|
|
|
|
|
60.
|
D'Orsi CJ, Karellas A, Costanza ME, Gaw VP. Preliminary report of an intervention to improve mammography skills of radiologists. Prog Clin Biol Res. 1989; 293:151-7.
|
|
|
|
|
61.
|
Zapka JG, Costanza ME, Greene HL. Breast cancer screening and primary care providers. Prog Clin Biol Res. 1989; 293:57-63.
|
|
|
|
|
62.
|
Costanza ME, Greene HL, Zapka JG, Barth RS, D'Orsi CJ, Wertheimer MD. Breast cancer screening for primary care physicians. Prog Clin Biol Res. 1989; 293:65-74.
|
|
|
|
|
63.
|
Foster RS, Costanza M, Foster JC, Hyman NH, Foster CB, DeMeules JE. Blood transfusions and survival after resection of cancers of the breast, colon, and lung: the need for prospective randomized trials. Transplant Proc. 1988 Dec; 20(6):1125-7.
|
|
|
|
|
64.
|
Freeman NJ, Costanza ME. 5-Fluorouracil-associated cardiotoxicity. Cancer. 1988 Jan 1; 61(1):36-45.
|
|
|
|
|
65.
|
Costanza ME, Gaw VP. Design, implementation, and evaluation of a longitudinal cancer curriculum. J Cancer Educ. 1987; 2(4):217-23.
|
|
|
|
|
66.
|
Wertheimer MD, Costanza ME, Dodson TF, D'Orsi C, Pastides H, Zapka JG. Increasing the effort toward breast cancer detection. JAMA. 1986 Mar 14; 255(10):1311-5.
|
|
|
|
|
67.
|
Griffin TW, Bogden AE, Reich SD, Antonelli D, Hunter RE, Ward A, Yu DT, Greene HL, Costanza ME. Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer. 1983 Dec 15; 52(12):2185-92.
|
|
|
|
|
68.
|
Vaage J, Costanza ME. Effects on metastases of drug therapy during developing and established tumor immunity. Int J Cancer. 1983 Dec 15; 32(6):759-63.
|
|
|
|
|
69.
|
Costanza ME. The medical management of breast cancer. Clin Obstet Gynecol. 1982 Jun; 25(2):433-41.
|
|
|
|
|
70.
|
Costanza ME. Diagnostic imperatives in internal medicine: the timely detection of treatable disease. Cancer. J Maine Med Assoc. 1980 Sep; 71(9):279-92, 295.
|
|
|
|
|
71.
|
Vaage J, Costanza ME. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma. Cancer Res. 1979 Nov; 39(11):4466-71.
|
|
|
|
|
72.
|
Costanza ME, Nathanson L, Schoenfeld D, Wolter J, Colsky J, Regelson W, Cunningham T, Sedransk N. Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer. 1977 Sep; 40(3):1010-5.
|
|
|
|
|
73.
|
Gagel RF, Costanza ME, DeLellis RA, Norton RA, Bloom SR, Miller HH, Ucci A, Nathanson L. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses. Arch Intern Med. 1976 Dec; 136(12):1429-35.
|
|
|
|
|
74.
|
Costanza ME, Nathanson L, Costello WG, Wolter J, Brunk SF, Colsky J, Hall T, Oberfield RA, Regelson W. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma. Cancer. 1976 Apr; 37(4):1654-9.
|
|
|
|
|
75.
|
Miller MS, Costanza ME, Li FP, Stolbach L, Stone R, Nathanson L. Familial colon cancer. Cancer. 1976 Feb; 37(2):946-8.
|
|
|
|
|
76.
|
Costanza ME, Dayal Y, Binder S, Nathanson L. Metastatic basal cell carcinoma: review, report of a case, and chemotherapy. Cancer. 1974 Jul; 34(1):230-5.
|
|
|
|
|
77.
|
Costanza ME, Das S, Nathanson L, Rule A, Schwartz RS. Proceedings: Carcinoembryonic antigen. Report of a screening study. Cancer. 1974 Feb; 33(2):583-90.
|
|
|
|
|
78.
|
Costanza ME, Nathanson L, Lenhard R, Wolter J, Colsky J, Oberfield RA, Schilling A. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea. Cancer. 1972 Dec; 30(6):1457-61.
|
|
|
|
